WVE
Wave Life Sciences is a biotechnology company focused on developing RNA-targeting therapeutics to treat rare and common diseases. Their research leverages a toolkit of RNA medicines and chemistry innovation, with programs spanning conditions such as Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity. The company emphasizes science-driven discovery through its PRISM platform to advance first- or best-in-class medicines aimed at improving human health. Headquartered in the United States, Wave Life Sciences collaborates with researchers and patients to translate genetic insights into transformative therapies.